Curi RMB Capital LLC Has $50.11 Million Stock Holdings in Danaher Corporation $DHR

Key Points

• Curi RMB Capital LLC increased its stake in Danaher Corporation by 10.0%, acquiring an additional 22,160 shares, bringing its total holdings to 244,074 shares valued at $50.1 million.
• Over 79% of Danaher's stock is owned by institutional investors, with several hedge funds recently adjusting their positions, including Bank Pictet & Cie which increased its stake by 22.8%.
• Danaher Corporation has a consensus rating of "Moderate Buy" among analysts, with a revised average price target of $246.35 following recent upgrades and downgrades by various research firms.

Curi RMB Capital LLC increased its stake in Danaher Corporation (NYSE:DHR - Free Report) by 10.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 244,074 shares of the conglomerate's stock after acquiring an additional 22,160 shares during the quarter. Danaher makes up 1.2% of Curi RMB Capital LLC's holdings, making the stock its 12th largest holding. Curi RMB Capital LLC's holdings in Danaher were worth $50,106,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of DHR. Heck Capital Advisors LLC purchased a new position in Danaher in the 4th quarter worth about $27,000. GHP Investment Advisors Inc. boosted its holdings in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares during the period. Sierra Ocean LLC increased its position in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher during the first quarter valued at approximately $31,000. Finally, Dunhill Financial LLC lifted its position in shares of Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 67 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the company's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 11.20% of the company's stock.

Analysts Set New Price Targets

Several research firms have weighed in on DHR. Barclays reiterated an "overweight" rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Royal Bank Of Canada set a $241.00 price objective on Danaher in a research report on Tuesday, September 2nd. Robert W. Baird upped their target price on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a report on Friday, July 18th. Finally, UBS Group reduced their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research report on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and an average price target of $246.35.

Danaher Stock Down 2.0%

Shares of Danaher stock traded down $3.95 during trading on Tuesday, hitting $194.68. 1,003,413 shares of the stock traded hands, compared to its average volume of 4,123,806. The company has a fifty day moving average price of $201.95 and a two-hundred day moving average price of $199.23. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90. The stock has a market cap of $139.40 billion, a P/E ratio of 41.42, a PEG ratio of 2.79 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.